Cancer Control Video Series | Cancer Sites | Cancer Risk Factors | Improving Cancer Outcomes | Browse Resources
In this segment, Dr. Peter Bach MD of Memorial Sloan Kettering Cancer Center explores the advances and complexities of screening for lung cancer.
Watch a little at a time by clicking on the videos below or watch the entire video at the bottom of the page.
- Cancer Screening Coverage
- Insurance coverage of cancer screening differs widely based on the insurer and state. The matrix on the linked page clarifies coverage.
- Cancer Screening: Guidelines and Insurance Coverage
- This PDF gives a detailed summary of the criteria a person may want to consider in the selection of their cancer screening options.
- Final Recommendation Statement: Lung Cancer Screening
- U.S. Preventive Services Task Force - Final Recommendation Statement: Lung Cancer: Screening, December 2013 - Provides an overview of lung cancer screening, including: recommendation summary, rationale of screening, clinical considerations, implementation of a lung cancer screening program, discussion of lung cancer.
- The Lung Cancer Screening Program Toolkit: 5 steps to get from inception to excellence
- The Advisory Board Company - The Lung Cancer Screening Program Toolkit - Provides information to build a stronger lung cancer screening program or start one from the beginning, the five steps include: evaluate your opportunity, establish program infrastructure, grow volumes, demonstrate program value, and achieve screening program excellence.
- Basic Information About Lung Cancer
- Center for Disease Control and Prevention - Basic Information About Lung Cancer - Provides a general overview of lung cancer, including: what lung cancer is, risk factor, symptoms, risk reduction, available screening tests, diagnosis and treatment, statistics, and what the CDC is doing.
- Lung Cancer Prevention- Health Professional Version (PDQ)
- National Cancer Institute - Lung Cancer Prevention (PDQ®)–Health Professional Version - Overview of lung cancer, including: who is at risk, interventions associated with decreased risk of lung cancer, interventions associated with an increased risk of lung cancer, and interventions that do not decrease risk of lung cancer.
The National Lung Screening Trial: Overview and Study Design Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. Aug 4 2011;365(5):395-409.
Benefits and Harms of CT Screening for Lung Cancer A Systematic Review - Peter B. Bach, MD, MAPP; Joshua N. Mirkin, BA; Thomas K. Oliver, BA; Christopher G. Azzoli, MD; Donald A. Berry, PhD; Otis W. Brawley, MD; Tim Byers, MD, MPH; Graham A. Colditz, MD, DrPH; Michael K. Gould, MD, MS; James R. Jett, MD; Anita L. Sabichi, MD; Rebecca Smith-Bindman, MD; Douglas E. Wood, MD; Amir Qaseem, MD, PhD, MHA; Frank C. Detterbeck, MD
- Explain screening recommendations
- Describe limitations of lung cancer screenings
Quiz and Certificate of Completion
Click Quiz and Certificate of Completion to take a short quiz and reeceive a certificate for this topic.
Dr. Peter Bach MD, Memorial Sloan Kettering Cancer Center
Dr. Peter Bach is the Director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering. Dr. Bach completed undergraduate studies at Harvard University and his Medical Degree from the University of Chicago Harris School. Dr. Bach’s research focuses on the cost and value of anticancer drugs. His work in lung cancer screening has lead to lung cancer screening guidelines and a risk-prediction model for disease.